The Cigna Group (NYSE:CI) Shares Gap Down on Disappointing Earnings
Shares of The Cigna Group (NYSE:CI – Get Free Report) gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at ...
Managed Healthcare Executive12h
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
Managed Healthcare Executive12h
Cigna's 2024 Revenue Increase Driven by Evernorth's Strong Performance
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
American Association of Individual Investors15h
3 Undervalued Health Care Providers & Services Stocks for Friday, January 31
Discover the top 3 undervalued Health Care Providers & Services stocks for Friday, January 31 based on AAII’s Stock Grades.
Benefits Pro18h
Specialty drugs and cancer surgery claims will push up stop-loss renewal prices, says Cigna CFO
The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.
Cigna price target lowered to $350 from $400 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is ...
Cigna Corporation (NYSE:CI) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...